HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
391.68
+4.74 (1.22%)
At close: Jun 26, 2026, 4:00 PM EDT
391.74
+0.06 (0.02%)
After-hours: Jun 26, 2026, 7:40 PM EDT

HCA Healthcare Stock Forecast

Stock Price Forecast

The 16 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 505.69, with a low estimate of 413 and a high estimate of 635. The average target predicts an increase of 29.11% from the current stock price of 391.68.

Analyst Consensus: Buy
Target Low Average Median High
Price $413 $505.69 $520 $635
Change +5.44% +29.11% +32.76% +62.12%

Analyst Ratings

The average analyst rating for HCA Healthcare stock from 25 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 131313131313
Buy 222222
Hold 889999
Sell 110000
Strong Sell 111111
Total 252525252525

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
TD Cowen
TD Cowen
Buy
Maintains
$390$431
Buy Maintains $390$431 +10.04% Jun 25, 2026
Scott Fidel
Goldman Sachs
Goldman Sachs
Buy
Maintains
$558
Buy Maintains $558 +42.46% Jun 12, 2026
Bernstein
Bernstein
Hold
Maintains
$413
Hold Maintains $413 +5.44% Jun 9, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$480$415
Hold Maintains $480$415 +5.95% Jun 9, 2026
Barclays
Barclays
Buy
Maintains
$496
Buy Maintains $496 +26.63% Jun 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
78.61B
from 75.60B
Increased by 3.98%
Revenue Next Year
82.34B
from 78.61B
Increased by 4.74%
EPS This Year
30.24
from 28.21
Increased by 7.20%
EPS Next Year
33.10
from 30.24
Increased by 9.44%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
58.75B60.23B64.97B70.60B75.60B78.61B82.34B
Revenue Growth
14.01%2.52%7.86%8.67%7.08%3.98%4.74%
EPS
21.1619.1518.9722.0028.3330.2133.16
EPS Growth
93.60%-9.50%-0.94%15.97%28.77%6.63%9.78%
Forward PE
-----12.9711.81
No. Analysts -----2222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 79.7B 83.7B
Avg 78.6B 82.3B
Low 77.0B 81.5B

Revenue Growth

Revenue Growth 202620272028
High
5.4%
6.5%
Avg
4.0%
4.7%
Low
1.9%
3.7%

EPS Forecast

EPS 202620272028
High 31.56 34.52
Avg 30.24 33.10
Low 29.10 31.61

EPS Growth

EPS Growth 202620272028
High
11.9%
14.1%
Avg
7.2%
9.4%
Low
3.2%
4.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.